Akebia Therapeutics | AKBA - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
Ardelyx USD -37.6M 37.2M 2026-03
Astellas Pharma JPY 141.83B 98.31B 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 219M 2.54B 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Exelixis USD 212.05M 1.58M 2026-06
Fresenius Medical Care EUR 218.38M 100.38M 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.53B 299M 2026-06
Kangmei Pharma CNY 52.6M 69.16M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pharma Mar EUR -972K 2.5M 2026-06
Prothena USD 32.72M 54.31M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Qiagen NV USD 103.4M 35.36M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Zealand Pharma A/S -394M 14.88M 2026-03
Zz Pientze Pharmaceu CNY 349.49M 393.99M 2026-06